The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOTAQ.L Regulatory News (OTAQ)

  • There is currently no data for OTAQ

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Open Offer and Placing

28 Oct 2022 15:34

OTAQ Plc (OTAQ)


Results of Open Offer and Placing

28-Oct-2022 / 15:34 GMT/BST

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

The issuer is solely responsible for the content of this announcement.


NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA, RUSSIA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018), AS AMENDED BY REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

 

OTAQ plc

("OTAQ", the "Company" or the "Group")

 

Results of Open Offer and Placing

 

OTAQ, a highly innovative technology company targeting the aquaculture, geotracking and offshore markets, is pleased to announce, that it has raised gross proceeds of approximately £751,577, pursuant to the Open Offer, as set out in the shareholder circular dated 12 October 2022 (the “Circular”).

 

The Company has received valid acceptances from Qualifying Shareholders under their Basic Entitlements in respect of 12,119,086 Open Offer Shares, and applications from Qualifying Shareholders under the Excess Application Facility in respect of a further 6,670,335 Open Offer Shares.  Total acceptances from Qualifying Shareholders under the Open Offer were accordingly received in respect of 18,789,421 Open Offer Shares, representing 62.2 per cent of the shares available to be applied for under the Open Offer.  Accordingly Excess Applications have been satisfied in full.

 

As announced on 12 October 2022 the Company has raised £2.0 million through the firm Placing of 50,000,000 New Ordinary Shares.  A further £400,000 has been raised by way of the Broker Option, which was exercised in full in respect of the subscription an additional 10,000,000 New Ordinary Shares as announced on 17 October 2022.  Together with the Open Offer the Company has raised gross proceeds of approximately £3.15 million (approximately £2.80 million, net of expenses), subject, inter alia, to the passing of the Resolutions at the Shareholder General Meeting to be held on 7 November 2022 and to Admission of the Enlarged Share Capital to trading on the Access Segment of the AQSE Growth Market, which is expected to take effect on 9 November 2022.

 

Pursuant to the Open Offer and Placing, including the exercise of the Broker Option, 19,697,355 Warrants will be granted to applicants under the Open Offer and placees under the Placing.

 

Working Capital

 

The net proceeds of the Placing, including the Broker Option, and Open Offer will provide the Company with sufficient funding for at least the next 12 months and will enable OTAQ to pursue the future strategy laid out in the Circular.

 

Directors’ participation in the Open Offer

 

The participation of certain of the Directors in the Open Offer is set out below

 

 

Number of Existing Ordinary Shares

Percentage of Existing Ordinary Capital

Number of Open Offer Shares

Number of New Ordinary Shares following AQSE Admission

Percentage of Enlarged Share Capital following AQSE Admission

Number of Warrants following AQSE Admission

Alex Hambro

312,273

0.83%

375,000

687,273

0.59%

93,750

Philip Newby(1)

875,820

2.32%

500,000

1,354,676

1.18%

125,000

George Watt

210,910

0.56%

400,000

610,910

0.52%

100,000

Sarah Stoten

368,648

0.98%

625,000

993,648

0.85%

156,250

 

  1. Philip Newby’s beneficial holding includes 349,606 Existing Ordinary Shares held by his wife, Diane Newby

 

Settlement and dealings

 

Application has been made to the Aquis Stock Exchange for the admission to trading on the Access Segment of the AQSE Growth Market (“Admission”) of the Enlarged Share Capital. It is expected that Admission will become effective at 8.00 a.m. on 9 November 2022.

 

Following completion of the Capital Reorganisation, the Placing, including the exercise of the Broker Option, and the Open Offer, details of which are set out in full in the Circular, the Enlarged Share Capital will be 116,547,473 ordinary shares of 1p each. The above figure of 116,547,473 may be used by Shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

 

Capitalised terms not otherwise defined in the text of this announcement are defined in the Circular dated 12 October 2022 which is available for inspection on the Company’s website, www.otaq.com.

 

Enquiries:

 

OTAQ plc

+44 (0)1524 748028

Alex Hambro, Non-Executive Chairman

 

Phil Newby, Chief Executive Officer

 

Matt Enright, Chief Financial Officer

 

 

 

Dowgate Capital Limited

+44 (0)20 3903 7715

(Financial Adviser, AQSE Corporate Adviser & Broker)

 

David Poutney / James Serjeant /
Russell Cook / Nicholas Chambers

 

 

 

Walbrook PR Limited

+44 (0)20 7933 8780 or

(Financial PR)

OTAQ@walbrookpr.com

Tom Cooper / Nick Rome

 07971221972 or 07748325236

 

 



ISIN: GB00BK6JQ137
Category Code: MSCM
TIDM: OTAQ
LEI Code: 213800CZGMYB5XTUXJ52
Sequence No.: 197639
EQS News ID: 1474965

 
End of Announcement EQS News Service


fncls.ssp?fn=show_t_gif&application_id=1474965&application_name=news&site_id=london_south_east
Date   Source Headline
7th Nov 20221:00 pmEQSResult of General Meeting
7th Nov 202212:00 pmEQSResult of General Meeting
4th Nov 20225:50 pmEQSFurther Placing
4th Nov 20224:51 pmEQSFurther Placing
28th Oct 20223:35 pmEQSResults of Open Offer and Placing
28th Oct 20223:34 pmEQSResults of Open Offer and Placing
18th Oct 20229:15 amEQSShare Incentive Plan Purchase - Director/PDMR Shareholding
18th Oct 20229:14 amEQSShare Incentive Plan Purchase - Director/PDMR Shareholding
17th Oct 202211:00 amEQSExercise of Broker Option
17th Oct 202211:00 amEQSExercise of Broker Option
12th Oct 20222:05 pmRNSSecond Price Monitoring Extn
12th Oct 20222:00 pmRNSPrice Monitoring Extension
12th Oct 202211:06 amRNSSecond Price Monitoring Extn
12th Oct 202211:00 amRNSPrice Monitoring Extension
12th Oct 20229:05 amRNSSecond Price Monitoring Extn
12th Oct 20229:00 amRNSPrice Monitoring Extension
12th Oct 20227:00 amEQSProposed Placing and Open Offer, Delisting & AQSE Admission, Capital Reorganisation and Board Appointments
12th Oct 20227:00 amEQSProposed Placing and Open Offer, Delisting & AQSE Admission, Capital Reorganisation and Board Appointments
30th Sep 20223:05 pmEQSResult of Annual General Meeting
30th Sep 20223:04 pmEQSResult of Annual General Meeting
22nd Sep 20221:40 pmEQSShare Incentive Plan Purchase, Director/PDMR Shareholding
22nd Sep 20221:39 pmEQSShare Incentive Plan Purchase, Director/PDMR Shareholding
21st Sep 20223:30 pmEQSFirst Order for Asset Tracking in Rail Industry
21st Sep 20223:30 pmEQSFirst Order for Asset Tracking in Rail Industry
20th Sep 202211:59 amEQSShare Price Movement
20th Sep 202211:59 amEQSShare Price Movement
20th Sep 20229:05 amRNSSecond Price Monitoring Extn
20th Sep 20229:00 amRNSPrice Monitoring Extension
5th Sep 20225:02 pmEQSPosting of Annual Report & Accounts and Notice of AGM
5th Sep 20225:01 pmEQSPosting of Annual Report & Accounts and Notice of AGM
17th Aug 20222:09 pmEQSShare Incentive Plan Purchase - Director/PDMR Shareholding
17th Aug 20222:08 pmEQSShare Incentive Plan Purchase - Director/PDMR Shareholding
1st Aug 20227:01 amEQSTotal Voting Rights
1st Aug 20227:00 amEQSTotal Voting Rights
27th Jul 20224:40 pmRNSSecond Price Monitoring Extn
27th Jul 20224:35 pmRNSPrice Monitoring Extension
27th Jul 20227:00 amRNSFinal Results
19th Jul 20227:00 amEQSShare Incentive Plan Purchase, Director/PDMR Shareholding and Total Voting Rights
19th Jul 20227:00 amEQSShare Incentive Plan Purchase, Director/PDMR Shareholding and Total Voting Rights
12th Jul 20227:00 amEQSAgreement with leading Chilean salmon & sea trout producer
12th Jul 20227:00 amEQSAgreement with leading Chilean salmon & sea trout producer
1st Jul 20227:00 amEQSTotal Voting Rights
1st Jul 20227:00 amEQSTotal Voting Rights
17th Jun 20221:16 pmEQSShare Incentive Plan purchase, Director / PDMR Shareholding, Total Voting Rights
17th Jun 20221:15 pmEQSShare Incentive Plan purchase, Director / PDMR Shareholding, Total Voting Rights
9th Jun 20227:01 amEQSOTAQ announces new agreement with Canadian aquaculture innovator for water quality ‘Sensor Globe’
9th Jun 20227:00 amEQSOTAQ announces new agreement with Canadian aquaculture innovator for water quality ‘Sensor Globe’
1st Jun 20227:01 amEQSTotal Voting Rights
31st May 20227:00 amEQSCycling Event Tracking Contract with NTT
17th May 20222:22 pmEQSSIP Purchase, PDMR Shareholding & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.